CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Class I - Dangerous
💊 Drugs Recalled: September 27, 2012 Genentech Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Genentech, Inc.
Reason for Recall:
Short Fill: some bottles contained less than 120-count per labeled claim.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Product Codes/Lot Numbers:

Lot #: a) M1365B01, Exp 04/15; b) M1365, Exp 04/15

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-097-2013

Related Recalls

Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.

Oct 18, 2022 Prescription Drugs Nationwide View Details →